(Date:1/5/2009)...tCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: ... present a corporate overview at the upcoming JP M...ay, January 14, 2009 at 7:30 a.m. PT at the Westin...ve and archived webcast of the company presentatio...e Idenix Investor Center at www.idenix.com . Ple...
(Date:1/5/2009)...tech, Inc. announces the launch of a,new campaign... in oncology,along with other key company develo.... The next generation of Pharmatech will feature a...Oncology, Inc., as well as a new web site,and eme...leadership team. , With the start of 2009, ...
(Date:1/5/2009)...te 700 patient trial of EGFR targeting, antibo...MISSISSAUGA, ON, Jan. 5 /PRNewswire-FirstCall/ - Y... AIM:YMBA), an oncology company that identifies, d... for patients worldwide, today announced that the ...ected nimotuzumab, YM,s EGFR-targeting drug, for e...
(Date:1/3/2009)...for both Botox and Fraxel Repair, Nissan Pilest Bo...s in-office clinical procedure studies to track th...to enhance the improvements of fractional CO2 skin...tant lip lines in women over the age of 40. , ...uary 1, 2009 -- To find a solution to lip lines (a...
Breaking Biology Technology:Pharmatech 2.0: Introducing Pharmatech Oncology 2YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 2YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 3YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE 4Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies 2Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies 3...ation of 520 kb targets from eukaryotic genomes Ca... Cat. No. 1 681 842 2 x 250 units , Cat..., , , Description , , , U...The system also includes , PCR buffers for ...ngths: , , PCR buffer 1 (10x co...
...ation of long targets (up to 35 kb) from eukaryoti..., , , , , , Description ,...and Pwo DNA Polymerase and another , thermo...lso includes , an optimized reaction buff... DNA (template DNA plus beta-globin primers). ,...
..., , , , , ... Primer anneal. temp. , Sens... Fidelity in RT , GC-rich structure... , , , total RNA ,... specific primer , oligo dt p...
..., , , , , ... Primer anneal. temp. , Sens... , Fidelity in PCR , Toler...c RNA , Tolerance , , ...-over , prevention dUTP/UNG c , ...
Other Biology Technology:Expand Long Template PCR System 2Expand 20 kbPLUS PCR System 2Reverse transcriptases suitable for two-step RT-PCRd 2Reverse transcriptases suitable for two-step RT-PCRd 3Reverse transcriptases suitable for one-step RT-PCRb 2(Date:12/16/2008)...Provided CML Biomarker Data for Studies , , ... Synvista Therapeutics, Inc. ( NYSE Alternext US...rating findings from studies that indicated that t...(A.G.E.) called carboxymethyl-lysine (CML) in olde...ction and arterial stiffness in older adults. Kits...
(Date:12/15/2008)...c Discoveries is Developing Therapies for Wounds, ...terials with Angiogenic Properties , , GILR...oday unveiled the company,s novel technology platf...h elements with angiogenic properties. Nanorod the... hair growth are being developed by the company, w...
(Date:12/14/2008)...PRNewswire-FirstCall/ -- In one of the,largest st...entists from,deCODE genetics (Nasdaq: DCGN ) tod...even new sites in the human genome found to influe... single-letter variations (SNPs) across the genome...herlands, and the United,States, and confirmed th...
(Date:12/12/2008)...wswire/ -- New data from two early,clinical studi...esistance to,Herceptin(R) (trastuzumab)* in women...se results support the initiation of a Phase III c...ial of RAD001 (proposed brand name,Afinitor(R)) i... presented today during the CTRC-AACR San Antonio,...
Breaking Medicine Technology:Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 2Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 3Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 4Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 5OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications 2OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications 3Major deCODE-led Study Underscores Role of the Brain in Obesity 2Major deCODE-led Study Underscores Role of the Brain in Obesity 3Major deCODE-led Study Underscores Role of the Brain in Obesity 4Major deCODE-led Study Underscores Role of the Brain in Obesity 5RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 2RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 3RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 4RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 5RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 6RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 7Vincent W Renz Joins NewCardio as President 2847 1Vincent W Renz Joins NewCardio as President 2847 2Vincent W Renz Joins NewCardio as President 2847 3Vincent W Renz Joins NewCardio as President 2847 4Researchers link cocoa flavanols to improved brain blood flow 4498 1Researchers link cocoa flavanols to improved brain blood flow 4498 2Researchers link cocoa flavanols to improved brain blood flow 4498 3CRDB Bases Growth Strategy on Misys BankFusion Platform 25492 1CRDB Bases Growth Strategy on Misys BankFusion Platform 25492 2CRDB Bases Growth Strategy on Misys BankFusion Platform 25492 3Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration 25489 1Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration 25489 2